Ivy T. Ngo
Freedman Normand Friedland LLP
- Address of record
- 2108 N Street, #15185, Sacramento, CA 95816, 786-924-2900
- ingo@fnf.law
- Phone
- (786) 924-2900
- Fax
- Fax 646-392-8842
Contact details as filed with the court in the cases below.
Case history
Publicly tracked matters where this attorney is listed as counsel.
Curb Mobility Antitrust Class Action
A proposed class action against Curb Mobility LLC alleging violations of antitrust law. The specific allegations are unclear from the limited docket information available, but the case concerns potentially anticompetitive conduct by the mobility services company.
- Filed
- February 13, 2026
- Represents
- Brendan Kretschmer
Mitchell v. Skillz Platform Inc.
A proposed class action against Skillz Platform Inc. filed in federal court in Northern California. The case caption and nature of suit description do not provide specific allegations, so the underlying claims cannot be determined from the docket information available.
- Filed
- January 21, 2026
- Represents
- Kel Mitchell, Giovanni Garza, Amy Masiker
Anthropic Copyright Settlement
Anthropic allegedly used copyrighted books without permission to train its artificial intelligence systems. Authors and publishers sued, claiming copyright infringement. Anthropic agreed to settle the class action lawsuit.
- Claim deadline
- March 30, 2026
- Represents
- ClaimsHero Holdings LLC
View Inc. Securities Litigation Settlement
Investors purchased View, Inc. (formerly CF Finance Acquisition Corp. II) securities during a specified period and are now participating in a settlement. The defendants have agreed to a settlement of $11 million to resolve securities claims, though the page does not specify what defendants allegedly did wrong or whether they admit liability.
- Settlement fund
- $11M
- Claim deadline
- December 5, 2025
- Represents
- Sweta Sonthalia
FibroGen, Inc. Securities Litigation Settlement
FibroGen and its executives allegedly misrepresented the safety profile and Phase III trial results of its anti-anemia drug Roxadustat in filings with the FDA. Investors claim the company's stock price was artificially inflated by these false statements and declined when the truth was revealed. The defendants deny all allegations of wrongdoing.
- Settlement fund
- $28.5M
- Claim deadline
- Represents
- Thomas Leonard
Labcorp Data Breach Settlement
Labcorp allegedly suffered a data breach involving customer diagnostic services information through American Medical Collection Agency. The company has agreed to settle for $35 million related to this alleged security breach.
- Settlement fund
- $35M
- Claim deadline
- September 3, 2026
- Represents
- JENNIFER RABEN
“Recovery” and “exposure” refer to total disclosed settlement funds in associated cases, not money personally won or lost by an attorney. Settlements generally resolve disputed allegations without a finding that either side won. Data comes from public court dockets and may be incomplete.